)
Edge14 Aug 2026
Deutsche Qualität: The Story of Birkenstock
From an 18th-century German shoemaker to a global footwear brand, how Birkenstock turned an orthopedic insole into the world's most popular sandal.
Medicure
Medicure (MPH) investor relations material
Medicure Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary14 Aug, 2026
Executive summary
Net revenue for the quarter ended June 30, 2026 was $7.4 million, up from $6.7 million year-over-year.
Net loss increased to $1.4 million ($0.14/share) from $786,000 ($0.08/share) year-over-year, mainly due to a $864,000 CMS liability and higher non-cash amortization expenses.
Adjusted EBITDA improved to $172,000 from negative $28,000 year-over-year, driven by pharmacy segment growth and ZYPITAMAG sales.
Financial highlights
Gross profit for the quarter was $3.2 million, down from $3.4 million year-over-year.
Cost of goods sold rose to $4.2 million from $3.2 million year-over-year.
Research and development expenses were $608,000, down from $741,000 year-over-year.
Unrestricted cash at June 30, 2026 was $1.8 million, down from $3.8 million at December 31, 2025.
Outlook and guidance
Marley Drug aims to grow ZYPITAMAG sales and expand exclusive product offerings and partnerships.
Continued investment in clinical development, including a Phase 3 trial for MC-1 targeting PNPO deficiency.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Medicure
- Revenue up 44–46% to CAD 7.9M, net loss narrows, MC-1 phase III trial progresses.MPH
Q1 2026 - Expanding branded drug sales and pharmacy reach while advancing R&D for rare diseases.MPHInvestor presentation
- Revenue grew 32% to CAD 28.9M, but net loss widened to CAD 7.1M on CMS rebate and R&D.MPHQ4 2025
- Revenue rose to CAD 8.2M, but net loss widened to CAD 1.4M amid Aggrastat declines and higher costs.MPHQ3 2025
- Revenue up 29% to $6.7M, net loss narrows, and pharmacy acquisitions drive growth.MPHQ2 2025
- Net income rose to $680K on $5.2M revenue, aided by a $1.9M legal settlement and pharmacy growth.MPHQ3 2024
- Q2 2024 net loss of CAD 1.2 million amid revenue decline and higher R&D costs.MPHQ2 2024
- Net loss of CAD 694,000 on CAD 5.5 million revenue as AGGRASTAT sales fell amid competition.MPHQ1 2025
- Stable revenue, higher net loss, and growth in Marley Drug and ZYPITAMAG segments.MPHQ4 2024
Next Medicure earnings date
Q3 202619 Nov, 2026
Medicure
Next Medicure earnings date
Q3 202619 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage